The global Oxygen Concentrators (OC) market, valued at US$1.20 billion in 2024, reached US$1.27 billion in 2025 and is projected to grow at a robust CAGR of 6.1%, reaching US$1.71 billion by 2030. This growth is primarily driven by rising incidences of respiratory diseases, the impact of air pollution, smoking, and an increasing focus on home-based healthcare solutions.
Urbanization and industrialization have contributed to worsening air quality in many regions, particularly in countries such as India and China, creating a growing patient population requiring oxygen therapy for conditions like COPD, asthma, and pulmonary fibrosis. Coupled with greater awareness and early diagnosis, this has fueled demand for both stationary and portable oxygen concentrators, as healthcare systems aim to deliver cost-effective, patient-friendly care.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=199087330
Portable Oxygen Concentrators: The Future of Mobility-Friendly Oxygen Therapy
The portable oxygen concentrator (POC) segment dominates the market due to rising demand for mobility-friendly solutions. Unlike traditional stationary units, POCs offer patients the freedom to move, travel, and maintain an active lifestyle without compromising oxygen therapy.
Patients with chronic respiratory diseases often require consistent oxygen delivery, making POCs ideal for daily use outside of clinical settings. Recent technological innovations have made these devices lighter, quieter, and more energy-efficient, while many are FAA-approved for air travel, adding convenience for frequent travelers.
The global aging population, coupled with an increase in chronic respiratory disease diagnoses, further drives POC adoption. Elderly patients and active adults alike benefit from the autonomy and flexibility offered by these devices, boosting quality of life and treatment adherence.
Home Care: Shaping the Oxygen Concentrators Market
By end-user, the home care segment accounted for the largest market share in 2024. Home-based oxygen therapy is not only cost-effective compared to extended hospital stays but also enhances patient comfort and convenience. Patients can maintain treatment continuity in familiar surroundings, reducing hospital overcrowding and minimizing risks of hospital-acquired infections.
Digital health solutions and telemedicine have further strengthened home-based care. Remote monitoring platforms allow healthcare providers to track oxygen saturation, device usage, and patient adherence in real-time, reducing the need for frequent hospital visits.
Insurance coverage and favorable reimbursement policies also incentivize home therapy. Governments and healthcare providers are actively promoting home care to alleviate pressure on healthcare systems, while manufacturers continue to innovate compact, user-friendly devices tailored for residential use. These factors collectively cement home care as a key driver of the oxygen concentrators market.
North America: Leading Regional Growth
North America has emerged as the largest regional market for oxygen concentrators. High prevalence of chronic respiratory diseases, supportive reimbursement frameworks, and a well-established home healthcare ecosystem are central to this leadership.
The U.S. is at the forefront, thanks to advanced healthcare infrastructure, early adoption of POC technology, and regulatory support, including FDA approvals. Additionally, growing patient preference for home-based care and telehealth solutions reinforces regional demand. Manufacturers in the U.S. benefit from strong distribution networks, innovation in portable and energy-efficient devices, and active public awareness campaigns.
These factors position North America as a model region where technology, policy, and patient-centric care converge, creating a conducive environment for sustained market growth.
Competitive Landscape: Leading Players and Strategies
The oxygen concentrators market is highly competitive, with key players leveraging product innovation, strategic partnerships, and geographic expansion. Some notable companies include:
Koninklijke Philips N.V. (Netherlands)
Philips is a market leader, offering both stationary and portable oxygen concentrators integrated with real-time monitoring, smart alarms, and connectivity features. Their focus on compact, user-friendly designs reduces caregiver burden and enhances patient comfort. Philips also emphasizes remote management capabilities, enabling healthcare providers to monitor patient health seamlessly.
Inogen Inc. (U.S.)
Inogen has established a strong foothold in portable oxygen concentrators designed for ambulatory patients. The company differentiates itself through direct-to-consumer sales, home delivery, and digital marketing, emphasizing lightweight, battery-efficient devices that enhance mobility. Continuous R&D investments focus on flow optimization, noise reduction, and wireless connectivity, reinforcing Inogen’s position in home-based long-term oxygen therapy.
Other prominent players include Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China), TEIJIN LIMITED (Japan), DAIKIN INDUSTRIES, Ltd. (Japan), ESAB Corporation (Switzerland), Caire, Inc. (U.S.), React Health (Ireland), Precision Medical Inc. (U.S.), and Drive DeVilbiss Healthcare (U.S.). These companies pursue strategic acquisitions, product launches, and global expansion to strengthen their market presence and cater to a growing international patient base.
Market Outlook and Future Trends
Several trends are expected to shape the oxygen concentrators market over the next five years:
- Technological Advancements: Lighter, quieter, and more energy-efficient devices will continue to enhance patient experience and adherence.
- Integration with Digital Health: Remote monitoring and telehealth integration will streamline home-based oxygen therapy, improve patient outcomes, and reduce healthcare costs.
- Growth in Emerging Markets: Increasing respiratory disease prevalence in Asia-Pacific, coupled with rising awareness and access to healthcare, will drive market expansion.
- Patient-Centric Design: Manufacturers are focusing on devices that are easy to use, portable, and travel-friendly, addressing both functional and lifestyle needs.
With these factors in play, the oxygen concentrators market is poised for steady growth, driven by home care adoption, portable device innovation, and regional expansion.
Conclusion
The oxygen concentrators market represents a critical intersection of healthcare innovation, patient-centered design, and strategic market growth. Rising respiratory disease prevalence, urban air pollution, and the global shift toward home-based care are creating strong demand for portable and stationary oxygen devices. Leading players such as Philips and Inogen continue to innovate, driving efficiency, mobility, and improved patient outcomes.
As the market expands to US$1.71 billion by 2030, opportunities abound for manufacturers, healthcare providers, and technology innovators to deliver cost-effective, accessible, and patient-friendly oxygen therapy solutions globally.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=199087330
